T1	Outcomes 1276 1316	presumed therapy related encephalopathy.
T2	Outcomes 1388 1403	adverse events:
T3	Outcomes 1406 1412	deaths
T4	Outcomes 1431 1449	complete remission
T5	Outcomes 1463 1471	relapses
T6	Outcomes 1545 1553	relapses
T7	Outcomes 1743 1773	first episode of CNS leukemia,
T8	Outcomes 1813 1825	CNS relapse,
T9	Outcomes 1830 1896	number of blasts in the spinal fluid at diagnosis of CNS leukemia.
T10	Outcomes 1968 1986	prolonged survival
T11	Outcomes 2021 2049	CSpRT is possibly less toxic
T12	Outcomes 2095 2108	subsequent BM
T13	Outcomes 2113 2131	testicular relapse